Related references
Note: Only part of the references are listed.Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18
Michelle L. Johnson Jones et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
Human Papillomavirus 16/18-Associated Cervical Lesions: Differences by Area-Based Measures of Race and Poverty
Monica M. Brackney et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2020)
Assessing sociodemographic differences in human papillomavirus vaccine impact studies in the United States: a systematic review using narrative synthesis
L. R. Avni-Singer et al.
PUBLIC HEALTH (2020)
Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 A Cross-sectional Study
Iacopo Baussano et al.
ANNALS OF INTERNAL MEDICINE (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Strong reduction in prevalence of HPV16/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina
Joaquin Victor Gonzalez et al.
PAPILLOMAVIRUS RESEARCH (2020)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
The projected timeframe until cervical cancer elimination in Australia: a modelling study
Michaela T. Hall et al.
LANCET PUBLIC HEALTH (2019)
Cervical Cancer Incidence in Young US Females After Human Papillomavirus Vaccine Introduction
Fangjian Guo et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)
The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016
David Mesher et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs
Lauri E. Markowitz et al.
VACCINE (2018)
Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
M. Jesus Purrinos-Hermida et al.
PLOS ONE (2018)
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
M. Arbyn et al.
EXPERT REVIEW OF VACCINES (2018)
Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study
Michael J. Silverberg et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap
Ross L. Cameron et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2017)
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study
Kimberley Kavanagh et al.
LANCET INFECTIOUS DISEASES (2017)
Declines in Human Papillomavirus (HPV)-Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008-2015
Linda M. Niccolai et al.
CLINICAL INFECTIOUS DISEASES (2017)
Factors associated with parental reasons for no-intent to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008-2012
Vinay K. Cheruvu et al.
BMC PEDIATRICS (2017)
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
Suzanne M. Garland et al.
CLINICAL INFECTIOUS DISEASES (2016)
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Eva Herweijer et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Population-Based Trends in High-Grade Cervical Lesions in the Early Human Papillomavirus Vaccine Era in the United States
Susan Hariri et al.
CANCER (2015)
Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data
Megan A. Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N. Tabrizi et al.
LANCET INFECTIOUS DISEASES (2014)
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Hammad Ali et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction
Jessica A. Kahn et al.
PEDIATRICS (2012)
Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap
Geoffrey A. Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003
Jean A. McDougall et al.
CANCER CAUSES & CONTROL (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Share Paper
